1-(2-Chlorophenyl)-6,7-dimethoxy-3-methyl-3,4-dihydroisoquinoline

This article concerns the synthesis and in silico evaluation of 1-(2-chlorophenyl)-6-7-dimethoxy-3-methyl-3,4-dihydrogioquinoline (DIQ). A variety of in silico simulations were applied to assess the potential biological activity and toxicity of the compound. Based on these analyses, the target molec...

Full description

Saved in:
Bibliographic Details
Published in:MolBank 2023-06, Vol.2023 (2), p.M1608
Main Authors: Milusheva, Miglena, Gledacheva, Vera, Stefanova, Iliyana, Nikolova, Stoyanka
Format: Article
Language:English
Subjects:
3,4-dihydroisoquinoline
Benzamide
Bioavailability
Biological activity
Bischler–Napieralski reaction
Chemical synthesis
Chlorine
Heterocyclic aromatic compounds
Hydrogen bonds
Identification and classification
in silico
Methods
Pharmaceuticals
Pharmacokinetics
synthesis
Toxicity
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:This article concerns the synthesis and in silico evaluation of 1-(2-chlorophenyl)-6-7-dimethoxy-3-methyl-3,4-dihydrogioquinoline (DIQ). A variety of in silico simulations were applied to assess the potential biological activity and toxicity of the compound. Based on these analyses, the target molecule DIQ was chosen for the synthesis. DIQ was synthesized from starting 2-chloro-N-(1-(3,4-dimethoxyphenyl)propan-2-yl)benzamide applied in the Bischler–Napieralski reaction. The newly obtained 3,4-dihydroisoquinoline derivative was fully analyzed and characterized. Based on the in silico calculations, the target molecule was synthesized with respect to its contractile activity, which is a permanent interest of our studies. Thus, further investigation into the possible medicinal applications of this compound is warranted in the future.
ISSN:1422-8599
1422-8599
DOI:10.3390/M1608